In a bid to demonstrate the efficacy and safety of marijuana as medicine, Tilray (NASDAQ: TLRY) has secured U.S. Drug Enforcement Agency approval to import capsules containing marijuana cannabinoids for a clinical trial in California.The study will evaluate marijuana's efficacy and safety in patients with essential tremors, a movement disorder that affects between 4.6% and 6.3% of seniors.